Association of Drug Susceptibility Testing Results for First- and Second-line Drugs With Treatment Outcomes in Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis-Reference-Cited by-同舟云学术

Association of Drug Susceptibility Testing Results for First- and Second-line Drugs With Treatment Outcomes in Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Published:2014-12-30 Issue:8 Volume:60 Page:1285-1286
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Hong-min W.,Xiao-Hong Z.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/60/8/1285/7452145/ciu1169.pdf

Reference3 articles.

1. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis

2. Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

3. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ternary Co-Crystal Phase Diagrams of Benzoic/4-Aminobenzoic Acid + Isoniazid + Ethanol/Acetonitrile at Several Temperatures;Journal of Chemical & Engineering Data;2024-05-17

2. Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates;BMC Microbiology;2022-10-03

3. Structural characterization of free-state and product-stateMycobacterium tuberculosismethionyl-tRNA synthetase reveals an induced-fit ligand-recognition mechanism;IUCrJ;2018-06-22

4. Novel Isoniazid cocrystals with aromatic carboxylic acids: Crystal engineering, spectroscopy and thermochemical investigations;Journal of Molecular Structure;2018-02

5. Reducing the Hygroscopicity of the Anti-Tuberculosis Drug (S,S)-Ethambutol Using Multicomponent Crystal Forms;Crystal Growth & Design;2017-04-04